Anticonvulsant Drug Development (ADD) Program
Anticonvulsant Drug Development (ADD) Program

Anticonvulsant Drug Development (ADD) Program Email Formats

Contact top employees from Anticonvulsant Drug Development (ADD)...
  • Anticonvulsant Drug Development (ADD) Program uses 6 formats total. Most emails use firstName-lastNameInitial: jane-d@pharmacy.utah.edu. This shows up in about 60% of work addresses.
  • Other common patterns:
    • firstNamelastNameInitial → janed@pharmacy.utah.edu
    • lastNamefirstName → doejane@pharmacy.utah.edu

Popular Anticonvulsant Drug Development (ADD) Program's Email Templates

Anticonvulsant Drug Dev...’s Employees Email Address FormatsPercentage

Employees Email Address Formats

firstName-lastNameInitial
jane-d@pharmacy.utah.eduPercentage: 60%

Employees Email Address Formats

lastNamefirstName
doejane@pharmacy.utah.eduPercentage: 17%

Employees Email Address Formats

firstNamelastNameInitial
janed@pharmacy.utah.eduPercentage: 11%

Employees Email Address Formats

firstNameInitial.lastNameInitial
j.d@pharmacy.utah.eduPercentage: 5%

Employees Email Address Formats

lastName_firstName
doe_jane@pharmacy.utah.eduPercentage: 5%

Employees Email Address Formats

firstNameInitiallastName
jdoe@pharmacy.utah.eduPercentage: 2%
Contact top employees from Anticonvulsant Drug Development (ADD)...
Christine Ligouri
Senior Research Analyst
View
Vanja Panic
Assistant Director (Operations)
View
Sharon Edwards
Senior Research Analyst
View
Ania Lobsinger
Undergraduate Research Assistant
View
Janint Camacho
Undergraduate Researcher
View

Data Privacy

GDPR Icon

GDPR COMPLIANT

SignalHire complies with the General Data Protection Regulation (GDPR). SignalHire follows GDPR requirements, including but not limited to rights of data subjects to access, correct, or delete their personal information and supports the right to be forgotten.

CCPA Icon

CCPA COMPLIANT

SignalHire is CCPA-compliant and provides California residents the right to know, access, opt out, and request deletion of their personal data.

BACK TO TOP